{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:29:21Z","timestamp":1794547761391,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dysregulation of Ca<jats:sup>2+<\/jats:sup>\/calmodulin-dependent protein kinase (CaMK)II is closely linked with myocardial hypertrophy and heart failure. However, the mechanisms that regulate CaMKII activity are incompletely understood. Here we show that protein arginine methyltransferase 1\u00a0(PRMT1) is essential for preventing cardiac CaMKII hyperactivation. Mice null for cardiac PRMT1 exhibit a rapid progression to dilated cardiomyopathy and heart failure within 2 months, accompanied by cardiomyocyte hypertrophy and fibrosis. Consistently, PRMT1 is downregulated in heart failure patients. PRMT1 depletion in isolated cardiomyocytes evokes hypertrophic responses with elevated remodeling gene expression, while PRMT1 overexpression protects against pathological responses to neurohormones. The level of active CaMKII is significantly elevated in PRMT1-deficient hearts or cardiomyocytes. PRMT1 interacts with and methylates CaMKII at arginine residues 9 and 275, leading to its inhibition. Accordingly, pharmacological inhibition of CaMKII restores contractile function in PRMT1-deficient mice. Thus, our data suggest that PRMT1 is a critical regulator of CaMKII to maintain cardiac function.<\/jats:p>","DOI":"10.1038\/s41467-018-07606-y","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T13:07:19Z","timestamp":1543237639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Cardiac specific PRMT1 ablation causes heart failure through CaMKII dysregulation"],"prefix":"10.1038","volume":"9","author":[{"given":"Jung-Hoon","family":"Pyun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Ji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myong-Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong-Yun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuan Anh","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong I.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seri","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hoi","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Sun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"key":"7606_CR1","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1161\/01.RES.0000069686.31472.C5","volume":"92","author":"T Zhang","year":"2003","unstructured":"Zhang, T. et al. The delta(C) isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ. Res. 92, 912\u2013919 (2003).","journal-title":"Circ. Res."},{"key":"7606_CR2","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.yjmcc.2011.01.012","volume":"51","author":"ME Anderson","year":"2011","unstructured":"Anderson, M. E., Brown, J. H. & Bers, D. M. CaMKII in myocardial hypertrophy and heart failure. J. Mol. Cell. Cardiol. 51, 468\u2013473 (2011).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"7606_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/01.RES.84.6.713","volume":"84","author":"B Hoch","year":"1999","unstructured":"Hoch, B., Meyer, R., Hetzer, P., Krause, E. G. & Karczewski, P. Identification and expression of delta-isoforms of the multifunctional Ca2+\/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ. Res. 84, 713\u2013721 (1999).","journal-title":"Circ. Res."},{"key":"7606_CR4","doi-asserted-by":"publisher","first-page":"24857","DOI":"10.1074\/jbc.M109.003186","volume":"284","author":"GH Little","year":"2009","unstructured":"Little, G. H. et al. Critical role of nuclear calcium\/calmodulin-dependent protein kinase II delta B in cardiomyocyte survival in cardiomyopathy. J. Biol. Chem. 284, 24857\u201324868 (2009).","journal-title":"J. Biol. Chem."},{"key":"7606_CR5","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1161\/01.RES.86.5.596","volume":"86","author":"T Netticadan","year":"2000","unstructured":"Netticadan, T., Temsah, R. M., Kawabata, K. & Dhalla, N. S. Sarcoplasmic reticulum Ca2+\/calmodulin-dependent protein kinase is altered in heart failure. Circ. Res. 86, 596\u2013605 (2000).","journal-title":"Circ. Res."},{"key":"7606_CR6","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1073\/pnas.0813013106","volume":"106","author":"J Backs","year":"2009","unstructured":"Backs, J. et al. The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc. Natl Acad. Sci. USA 106, 2342\u20132347 (2009).","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"7606_CR7","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.15252\/emmm.201403848","volume":"6","author":"M Weinreuter","year":"2014","unstructured":"Weinreuter, M. et al. CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia\/reperfusion injury. EMBO Mol. Med. 6, 1231\u20131245 (2014).","journal-title":"EMBO Mol. Med."},{"key":"7606_CR8","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1172\/JCI27438","volume":"116","author":"J Backs","year":"2006","unstructured":"Backs, J., Song, K. H., Bezprozvannaya, S., Chang, S. R. & Olson, E. N. CaM kinase II selectively signals to histone deacetylase 4 during cardiornyocyte hypertrophy. J. Clin. Investig. 116, 1853\u20131864 (2006).","journal-title":"J. Clin. Investig."},{"key":"7606_CR9","doi-asserted-by":"publisher","first-page":"35078","DOI":"10.1074\/jbc.M707083200","volume":"282","author":"T Zhang","year":"2007","unstructured":"Zhang, T. et al. CaMKII delta isoforms differentially affect calcium handling but similarly regulate HDAC\/MEF2 transcriptional responses. J. Biol. Chem. 282, 35078\u201335087 (2007).","journal-title":"J. Biol. Chem."},{"key":"7606_CR10","doi-asserted-by":"publisher","first-page":"14400","DOI":"10.1073\/pnas.260501497","volume":"97","author":"TA McKinsey","year":"2000","unstructured":"McKinsey, T. A., Zhang, C. L. & Olson, E. N. Activation of the myocyte enhancer factor-2 transcription factor by calcium\/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc. Natl Acad. Sci. U.S.A. 97, 14400\u201314405 (2000).","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"7606_CR11","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1161\/CIRCRESAHA.111.243956","volume":"110","author":"PD Swaminathan","year":"2012","unstructured":"Swaminathan, P. D., Purohit, A., Hund, T. J. & Anderson, M. E. Calmodulin-Dependent Protein Kinase II: Linking Heart Failure and Arrhythmias. Circ. Res. 110, 1661\u20131677 (2012).","journal-title":"Circ. Res."},{"key":"7606_CR12","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1074\/jbc.M108525200","volume":"277","author":"T Zhang","year":"2002","unstructured":"Zhang, T. et al. The cardiac-specific nuclear delta(B) isoform of Ca2+\/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity. J. Biol. Chem. 277, 1261\u20131267 (2002).","journal-title":"J. Biol. Chem."},{"key":"7606_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1161\/CIRCRESAHA.107.169755","volume":"102","author":"J Bossuyt","year":"2008","unstructured":"Bossuyt, J. et al. Ca2+\/Calmodulin-Dependent protein kinase II delta and protein kinase D overexpression reinforce the histone deacetylase 5 redistribution in heart failure. Circ. Res. 102, 695\u2013702 (2008).","journal-title":"Circ. Res."},{"key":"7606_CR14","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1517\/14728222.2013.809064","volume":"17","author":"BD Westenbrink","year":"2013","unstructured":"Westenbrink, B. D., Edwards, A. G., McCulloch, A. D. & Brown, J. H. The promise of CaMKII inhibition for heart disease: preventing heart failure and arrhythmias. Expert. Opin. Ther. Targets 17, 889\u2013903 (2013).","journal-title":"Expert. Opin. Ther. Targets"},{"key":"7606_CR15","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/CIRCHEARTFAILURE.109.865279","volume":"2","author":"CM Sag","year":"2009","unstructured":"Sag, C. M. et al. Calcium\/Calmodulin-Dependent Protein Kinase II Contributes to Cardiac Arrhythmogenesis in Heart Failure. Circ.-Heart Fail. 2, 664\u2013675 (2009).","journal-title":"Circ.-Heart Fail."},{"key":"7606_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cardiores.2006.12.003","volume":"73","author":"M Vila-Petroff","year":"2007","unstructured":"Vila-Petroff, M. et al. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. Cardiovasc. Res. 73, 689\u2013698 (2007).","journal-title":"Cardiovasc. Res."},{"key":"7606_CR17","doi-asserted-by":"publisher","first-page":"H3065","DOI":"10.1152\/ajpheart.00353.2006","volume":"291","author":"Y Yang","year":"2006","unstructured":"Yang, Y. et al. Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. Am. J. Physiol.-Heart Circ. Physiol. 291, H3065\u2013H3075 (2006).","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"7606_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nm1215","volume":"11","author":"R Zhang","year":"2005","unstructured":"Zhang, R. et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat. Med. 11, 409\u2013417 (2005).","journal-title":"Nat. Med."},{"key":"7606_CR19","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1161\/CIRCRESAHA.113.301651","volume":"113","author":"M Luo","year":"2013","unstructured":"Luo, M. & Anderson, M. E. Mechanisms of Altered Ca2+Handling in Heart Failure. Circ. Res. 113, 690\u2013708 (2013).","journal-title":"Circ. Res."},{"key":"7606_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.cardiores.2004.04.026","volume":"63","author":"T Zhang","year":"2004","unstructured":"Zhang, T. & Brown, J. H. Role of Ca2+\/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc. Res. 63, 476\u2013486 (2004).","journal-title":"Cardiovasc. Res."},{"key":"7606_CR21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1152\/physrev.00018.2010","volume":"91","author":"JR Erickson","year":"2011","unstructured":"Erickson, J. R., He, B. J., Grumbach, I. M. & Anderson, M. E. CaMKII in the cardiovascular system: Sensing redox statES. Physiol. Rev. 91, 889\u2013915 (2011).","journal-title":"Physiol. Rev."},{"key":"7606_CR22","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2008.02.048","volume":"133","author":"JR Erickson","year":"2008","unstructured":"Erickson, J. R. et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 133, 462\u2013474 (2008).","journal-title":"Cell"},{"key":"7606_CR23","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/nm.2506","volume":"17","author":"BJ He","year":"2011","unstructured":"He, B. J. et al. Oxidation of CaMKII determines the cardiotoxic effects of aldosterone. Nat. Med. 17, 1610\u2013U1125 (2011).","journal-title":"Nat. Med."},{"key":"7606_CR24","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.phrs.2009.07.006","volume":"60","author":"TB Nicholson","year":"2009","unstructured":"Nicholson, T. B., Chen, T. & Richard, S. The physiological and pathophysiological role of PRMT1-mediated protein arginine methylation. Pharmacol. Res. 60, 466\u2013474 (2009).","journal-title":"Pharmacol. Res."},{"key":"7606_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molcel.2008.12.013","volume":"33","author":"MT Bedford","year":"2009","unstructured":"Bedford, M. T. & Clarke, S. G. Protein arginine methylation in mammals: Who, what, and why. Mol. Cell 33, 1\u201313 (2009).","journal-title":"Mol. Cell"},{"key":"7606_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrm3915","volume":"16","author":"KK Biggar","year":"2015","unstructured":"Biggar, K. K. & Li, S. S. C. Non-histone protein methylation as a regulator of cellular signalling and function. Nat. Rev. Mol. Cell Biol. 16, 5\u201317 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"7606_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4161\/cc.27353","volume":"13","author":"H Wei","year":"2014","unstructured":"Wei, H., Mundade, R., Lange, K. C. & Lu, T. Protein arginine methylation of non-histone proteins and its role in diseases. Cell Cycle 13, 32\u201341 (2014).","journal-title":"Cell Cycle"},{"key":"7606_CR28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1101\/gad.1279805","volume":"19","author":"FM Boisvert","year":"2005","unstructured":"Boisvert, F. M., Dery, U., Masson, J. Y. & Richard, S. Arginine methylation of MRE11 by PRMT1 is required for DNA damage checkpoint control. Genes Dev. 19, 671\u2013676 (2005).","journal-title":"Genes Dev."},{"key":"7606_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.molcel.2005.04.003","volume":"18","author":"MT Bedford","year":"2005","unstructured":"Bedford, M. T. & Richard, S. Arginine methylation: An emerging regulator of protein function. Mol. Cell 18, 263\u2013272 (2005).","journal-title":"Mol. Cell"},{"key":"7606_CR30","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1002\/hep.25809","volume":"56","author":"D Choi","year":"2012","unstructured":"Choi, D. et al. Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO1-dependent manner. Hepatology 56, 1546\u20131556 (2012).","journal-title":"Hepatology"},{"key":"7606_CR31","doi-asserted-by":"crossref","unstructured":"Blanc, R. S., et al. Arginine methylation by PRMT1 regulates muscle stem cell fate. Mol. Cell. Biol. 37, pii: e00457-16 (2017).","DOI":"10.1128\/MCB.00457-16"},{"key":"7606_CR32","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1101\/gad.1333905","volume":"19","author":"SM Huang","year":"2005","unstructured":"Huang, S. M., Litt, M. & Felsenfeld, G. Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications. Genes Dev. 19, 1885\u20131893 (2005).","journal-title":"Genes Dev."},{"key":"7606_CR33","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/j.febslet.2010.11.010","volume":"585","author":"A Di Lorenzo","year":"2011","unstructured":"Di Lorenzo, A. & Bedford, M. T. Histone arginine methylation. FEBS Lett. 585, 2024\u20132031 (2011).","journal-title":"FEBS Lett."},{"key":"7606_CR34","doi-asserted-by":"publisher","first-page":"H174","DOI":"10.1152\/ajpheart.00295.2015","volume":"310","author":"R Martherus","year":"2016","unstructured":"Martherus, R. et al. Accelerated cardiac remodeling in desmoplakin transgenic mice in response to endurance exercise is associated with perturbed Wnt\/beta-catenin signaling. Am. J. Physiol.-Heart Circ. Physiol. 310, H174\u2013H187 (2016).","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"7606_CR35","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1161\/01.RES.0000241482.19382.c6","volume":"99","author":"Z Yang","year":"2006","unstructured":"Yang, Z. et al. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia\/cardiomyopathy. Circ. Res. 99, 646\u2013655 (2006).","journal-title":"Circ. Res."},{"key":"7606_CR36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1083\/jcb.201406020","volume":"208","author":"LV Albrecht","year":"2015","unstructured":"Albrecht, L. V. et al. GSK3-and PRMT-1-dependent modifications of desmoplakin control desmoplakin-cytoskeleton dynamics. J. Cell Biol. 208, 597\u2013612 (2015).","journal-title":"J. Cell Biol."},{"key":"7606_CR37","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.cardiores.2006.11.005","volume":"73","author":"LS Maier","year":"2007","unstructured":"Maier, L. S. & Bers, D. M. Role of Ca2+\/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc. Res. 73, 631\u2013640 (2007).","journal-title":"Cardiovasc. Res."},{"key":"7606_CR38","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1161\/CIRCULATIONAHA.110.982298","volume":"122","author":"RJ van Oort","year":"2010","unstructured":"van Oort, R. J. et al. Ryanodine receptor phosphorylation by calcium\/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure. Circulation 122, 2669\u2013U2155 (2010).","journal-title":"Circulation"},{"key":"7606_CR39","doi-asserted-by":"publisher","first-page":"10274","DOI":"10.1073\/pnas.1005843107","volume":"107","author":"A Kushnir","year":"2010","unstructured":"Kushnir, A., Shan, J., Betzenhauser, M. J., Reiken, S. & Marks, A. R. Role of CaMKII delta phosphorylation of the cardiac ryanodine receptor in the force frequency relationship and heart failure. Proc. Natl Acad. Sci. USA 107, 10274\u201310279 (2010).","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"7606_CR40","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.cardiores.2003.12.007","volume":"62","author":"NJ Severs","year":"2004","unstructured":"Severs, N. J. et al. Gap junction alterations in human cardiac disease. Cardiovasc. Res. 62, 368\u2013377 (2004).","journal-title":"Cardiovasc. Res."},{"key":"7606_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejphar.2015.10.030","volume":"768","author":"P Michela","year":"2015","unstructured":"Michela, P., Velia, V., Aldo, P. & Ada, P. Role of connexin 43 in cardiovascular diseases. Eur. J. Pharmacol. 768, 71\u201376 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"7606_CR42","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/j.ehj.2004.08.007","volume":"25","author":"BEJ Teunissen","year":"2004","unstructured":"Teunissen, B. E. J., Jongsma, H. J. & Bierhuizen, M. F. A. Regulation of myocardial connexins during hypertrophic remodelling. Eur. Heart J. 25, 1979\u20131989 (2004).","journal-title":"Eur. Heart J."},{"key":"7606_CR43","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1172\/JCI39262","volume":"119","author":"ME Anderson","year":"2009","unstructured":"Anderson, M. E. CaMKII and a failing strategy for growth in heart. J. Clin. Investig. 119, 1082\u20131085 (2009).","journal-title":"J. Clin. Investig."},{"key":"7606_CR44","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1172\/JCI57833","volume":"121","author":"PD Swaminathan","year":"2011","unstructured":"Swaminathan, P. D. et al. Oxidized CaMKII causes cardiac sinus node dysfunction in mice. J. Clin. Investig. 121, 3277\u20133288 (2011).","journal-title":"J. Clin. Investig."},{"key":"7606_CR45","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.hrthm.2011.04.027","volume":"8","author":"ME Anderson","year":"2011","unstructured":"Anderson, M. E. Pathways for CaMKII activation in disease. Heart Rhythm. 8, 1501\u20131503 (2011).","journal-title":"Heart Rhythm."},{"key":"7606_CR46","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1021\/pr200339n","volume":"10","author":"P Beltran-Alvarez","year":"2011","unstructured":"Beltran-Alvarez, P., Pagans, S. & Brugada, R. The cardiac sodium channel is post-translationally modified by arginine methylation. J. Proteome Res. 10, 3712\u20133719 (2011).","journal-title":"J. Proteome Res."},{"key":"7606_CR47","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000078178","volume":"41","author":"YF Chen","year":"2004","unstructured":"Chen, Y. F., Zhang, A. Y., Zou, A. P., Campbell, W. B. & Li, P. L. Protein methylation activates reconstituted ryanodine receptor-Ca2+release channels from coronary artery myocytes. J. Vasc. Res. 41, 229\u2013240 (2004).","journal-title":"J. Vasc. Res."},{"key":"7606_CR48","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.pharmthera.2005.04.003","volume":"107","author":"M Yano","year":"2005","unstructured":"Yano, M., Yamamoto, T., Ikemoto, N. & Matsuzaki, M. Abnormal ryanodine receptor function in heart failure. Pharmacol. Ther. 107, 377\u2013391 (2005).","journal-title":"Pharmacol. Ther."},{"key":"7606_CR49","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.molcel.2008.09.013","volume":"32","author":"K Yamagata","year":"2008","unstructured":"Yamagata, K. et al. Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt. Mol. Cell 32, 221\u2013231 (2008).","journal-title":"Mol. Cell"},{"key":"7606_CR50","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/ncb2158","volume":"13","author":"JM Hsu","year":"2011","unstructured":"Hsu, J. -M. et al. Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation. Nat. Cell Biol. 13, 174\u2013U151 (2011).","journal-title":"Nat. Cell Biol."},{"key":"7606_CR51","doi-asserted-by":"crossref","unstructured":"Lu, Y., Ma, W., Li, Z., Lu, J. & Wang, X. The interplay between p16 serine phosphorylation and arginine methylation determines its function in modulating cellular apoptosis and senescence. Sci. Rep. 7, 41390 (2017).","DOI":"10.1038\/srep41390"},{"key":"7606_CR52","doi-asserted-by":"publisher","first-page":"E1345","DOI":"10.1073\/pnas.1615105114","volume":"114","author":"MH Jeong","year":"2017","unstructured":"Jeong, M. -H. et al. Cdon deficiency causes cardiac remodeling through hyperactivation of WNT\/beta-catenin signaling. Proc. Natl Acad. Sci. U. S. A. 114, E1345\u2013E1354 (2017).","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"7606_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yjmcc.2016.01.013","volume":"93","author":"MH Jeong","year":"2016","unstructured":"Jeong, M. -H. et al. A Shh coreceptor Cdo is required for efficient cardiomyogenesis of pluripotent stem cells. J. Mol. Cell. Cardiol. 93, 57\u201366 (2016).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"7606_CR54","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.2337\/db15-1500","volume":"65","author":"HJ Jeong","year":"2016","unstructured":"Jeong, H. -J. et al. Prmt7 deficiency causes reduced skeletal muscle oxidative metabolism and age-related obesity. Diabetes 65, 1868\u20131882 (2016).","journal-title":"Diabetes"},{"key":"7606_CR55","doi-asserted-by":"crossref","unstructured":"Jeong, M. -H., et al. Cdo suppresses canonical Wnt signalling via interaction with Lrp6 thereby promoting neuronal differentiation. Nat. Commun. 5, 5455 (2014).","DOI":"10.1038\/ncomms6455"},{"key":"7606_CR56","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1242\/jcs.152470","volume":"127","author":"JY Lee","year":"2014","unstructured":"Lee, J. Y. et al. Promiscuous methionyl-tRNA synthetase mediates adaptive mistranslation to protect cells against oxidative stress. J. Cell Sci. 127, 4234\u20134245 (2014).","journal-title":"J. Cell Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07606-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07606-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07606-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T21:04:32Z","timestamp":1671570272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07606-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["7606"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-07606-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]},"assertion":[{"value":"25 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5107"}}